Leadership with Purpose

Peter DeYoung is the CEO of Piramal Global Pharma and a member of the Piramal Pharma Operating Board. Piramal Global Pharma is comprised of Piramal Pharma Solutions and Piramal Critical Care business units. In his current role, Peter is responsible for steering strategy and driving profitable growth for these businesses.

Prior to this, he spearheaded several leadership roles within the Piramal Group, including CEO of Piramal Critical Care and President of Life Sciences.

Previously, Peter DeYoung worked in various investing and consulting roles in healthcare in the USA, Europe and India. He joined McKinsey & Company in New York after graduating from Princeton, where he worked several projects for pharmaceutical and medical device companies. He was then seconded by McKinsey to the World Economic Forum in Geneva, Switzerland as part of the Global Health Initiative. Peter DeYoung returned to McKinsey in New York and later in Mumbai, where he focused on the pharmaceutical and healthcare practice. Later, he joined the Blackstone Group’s Private Equity Division in Mumbai where he was part of the deal team for several significant transactions, across a wide spectrum of industry sectors in India.

Peter DeYoung holds a Master’s Degree in Business Administration from Stanford University (Arjay Miller Scholar), California, USA and a Bachelor’s of Science Degree in Engineering from Princeton University, New Jersey, USA, graduating summa cum laude.